PUBLISHER: TechNavio | PRODUCT CODE: 2030543
PUBLISHER: TechNavio | PRODUCT CODE: 2030543
Global Botanical And Plant-Derived Drugs Market 2026-2030
The global botanical and plant-derived drugs market is forecasted to grow by USD 21744.7 mn during 2025-2030, accelerating at a CAGR of 7.4% during the forecast period. The report on the global botanical and plant-derived drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing integration of traditional medicine with modern scientific advancements, modernization of global regulatory frameworks, advancements in biotechnology and standardized production technologies.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 7.2% |
| CAGR | 7.4% |
| Incremental Value | $21744.7 mn |
Technavio's global botanical and plant-derived drugs market is segmented as below:
By Type
- Oral
- Injectables
- Topicals
By Application
- Infectious diseases
- Central nervous system
- Cardiovascular diseases
- Respiratory diseases
- Others
By Source
- Plant-based
- Algae-based
- Fungi-based
Geography
- Asia
- Europe
- Germany
- France
- UK
- Italy
- Spain
- The Netherlands
- North America
- US
- Canada
- Mexico
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the integration of advanced biotechnological synthesis and standardized extraction as one of the prime reasons driving the global botanical and plant-derived drugs market growth during the next few years. Also, expansion of regulatory frameworks and clinical validation in asia-pacific and rising demand for precision phytotherapy in chronic and rare disease management will lead to sizable demand in the market.
The report on the global botanical and plant-derived drugs market covers the following areas:
- Global botanical and plant-derived drugs market sizing
- Global botanical and plant-derived drugs market forecast
- Global botanical and plant-derived drugs market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global botanical and plant-derived drugs market vendors that include Bausch Health Companies Inc., Bayer AG, BioHarvest Sciences Inc., Boehringer Ingelheim GmbH, Devonian Health Group Inc., Emery Pharma LLC, F. Hoffmann La Roche Ltd., Hetero Labs Ltd., Huisong Pharmaceuticals, Jaguar Health Inc., Jazz Pharmaceuticals Plc, Merck KGaA, Novartis AG, Pierre Fabre SA, Protalix Biotherapeutics Inc., Sanofi SA, Sun Pharmaceutical Industries, Vertex Pharmaceuticals Inc., Willmar Schwabe GmbH & Co. KG, Wilson Drugs. Also, the global botanical and plant-derived drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Source
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Botanical And Plant-Derived Drugs Market 2020 - 2024
- Historic Market Size - Data Table on Global Botanical And Plant-Derived Drugs Market 2020 - 2024 ($ million)
- 5.2 Type segment analysis 2020 - 2024
- Historic Market Size - Type Segment 2020 - 2024 ($ million)
- 5.3 Application segment analysis 2020 - 2024
- Historic Market Size - Application Segment 2020 - 2024 ($ million)
- 5.4 Source segment analysis 2020 - 2024
- Historic Market Size - Source Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on Global Botanical and Plant-Derived Drugs Market
- 6.2 Impact of geopolitical conflicts on Global Botanical and Plant-Derived Drugs Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Type
- 8.1 Market segments
- 8.2 Comparison by Type
- 8.3 Oral - Market size and forecast 2025-2030
- 8.4 Injectables - Market size and forecast 2025-2030
- 8.5 Topicals - Market size and forecast 2025-2030
- 8.6 Market opportunity by Type
- Market opportunity by Type ($ million)
9 Market Segmentation by Application
- 9.1 Market segments
- 9.2 Comparison by Application
- 9.3 Infectious diseases - Market size and forecast 2025-2030
- 9.4 Central nervous system - Market size and forecast 2025-2030
- 9.5 Cardiovascular diseases - Market size and forecast 2025-2030
- 9.6 Respiratory diseases - Market size and forecast 2025-2030
- 9.7 Others - Market size and forecast 2025-2030
- 9.8 Market opportunity by Application
- Market opportunity by Application ($ million)
10 Market Segmentation by Source
- 10.1 Market segments
- 10.2 Comparison by Source
- 10.3 Plant-based - Market size and forecast 2025-2030
- 10.4 Algae-based - Market size and forecast 2025-2030
- 10.5 Fungi-based - Market size and forecast 2025-2030
- 10.6 Market opportunity by Source
- Market opportunity by Source ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 Asia - Market size and forecast 2025-2030
- 12.3.1 China - Market size and forecast 2025-2030
- 12.3.2 India - Market size and forecast 2025-2030
- 12.3.3 Japan - Market size and forecast 2025-2030
- 12.3.4 South Korea - Market size and forecast 2025-2030
- 12.3.5 Thailand - Market size and forecast 2025-2030
- 12.3.6 Vietnam - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 France - Market size and forecast 2025-2030
- 12.4.3 UK - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.5 North America - Market size and forecast 2025-2030
- 12.5.1 US - Market size and forecast 2025-2030
- 12.5.2 Canada - Market size and forecast 2025-2030
- 12.5.3 Mexico - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.3 UAE - Market size and forecast 2025-2030
- 12.6.4 Turkey - Market size and forecast 2025-2030
- 12.6.5 South Africa - Market size and forecast 2025-2030
- 12.6.6 Egypt - Market size and forecast 2025-2030
- 12.6.7 Argentina - Market size and forecast 2025-2030
- 12.6.8 Nigeria - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Increasing integration of traditional medicine with modern scientific advancements
- Modernization of global regulatory frameworks
- Advancements in biotechnology and standardized production technologies
- 13.2 Market challenges
- Standardization of complex phytochemical matrices and variability in raw materials
- Regulatory harmonization and stringent clinical validation requirements
- Supply chain vulnerabilities and intellectual property constraints
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Integration of advanced biotechnological synthesis and standardized extraction
- Expansion of regulatory frameworks and clinical validation in Asia-Pacific
- Rising demand for precision phytotherapy in chronic and rare disease management
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Bausch Health Companies Inc.
- Bausch Health Companies Inc. - Overview
- Bausch Health Companies Inc. - Business segments
- Bausch Health Companies Inc. - Key offerings
- Bausch Health Companies Inc. - Segment focus
- SWOT
- 15.5 Bayer AG
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- SWOT
- 15.6 Boehringer Ingelheim GmbH
- Boehringer Ingelheim GmbH - Overview
- Boehringer Ingelheim GmbH - Product / Service
- Boehringer Ingelheim GmbH - Key offerings
- SWOT
- 15.7 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- 15.8 Hetero Labs Ltd.
- Hetero Labs Ltd. - Overview
- Hetero Labs Ltd. - Product / Service
- Hetero Labs Ltd. - Key offerings
- SWOT
- 15.9 Huisong Pharmaceuticals
- Huisong Pharmaceuticals - Overview
- Huisong Pharmaceuticals - Product / Service
- Huisong Pharmaceuticals - Key offerings
- SWOT
- 15.10 Jaguar Health Inc.
- Jaguar Health Inc. - Overview
- Jaguar Health Inc. - Business segments
- Jaguar Health Inc. - Key offerings
- Jaguar Health Inc. - Segment focus
- SWOT
- 15.11 Jazz Pharmaceuticals Plc
- Jazz Pharmaceuticals Plc - Overview
- Jazz Pharmaceuticals Plc - Product / Service
- Jazz Pharmaceuticals Plc - Key news
- Jazz Pharmaceuticals Plc - Key offerings
- SWOT
- 15.12 Merck KGaA
- Merck KGaA - Overview
- Merck KGaA - Business segments
- Merck KGaA - Key news
- Merck KGaA - Key offerings
- Merck KGaA - Segment focus
- SWOT
- 15.13 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
- 15.14 Pierre Fabre SA
- Pierre Fabre SA - Overview
- Pierre Fabre SA - Product / Service
- Pierre Fabre SA - Key offerings
- SWOT
- 15.15 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- SWOT
- 15.16 Sun Pharmaceutical Industries
- Sun Pharmaceutical Industries - Overview
- Sun Pharmaceutical Industries - Business segments
- Sun Pharmaceutical Industries - Key news
- Sun Pharmaceutical Industries - Key offerings
- Sun Pharmaceutical Industries - Segment focus
- SWOT
- 15.17 Vertex Pharmaceuticals Inc.
- Vertex Pharmaceuticals Inc. - Overview
- Vertex Pharmaceuticals Inc. - Product / Service
- Vertex Pharmaceuticals Inc. - Key offerings
- SWOT
- 15.18 Willmar Schwabe GmbH & Co. KG
- Willmar Schwabe GmbH & Co. KG - Overview
- Willmar Schwabe GmbH & Co. KG - Product / Service
- Willmar Schwabe GmbH & Co. KG - Key offerings
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
